DEBORAH PESTRAK: Open Payments
NPI 1396187456 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 51 payments from 13 companies in 2025. Trend: 2023 $584 · 2024 $719 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $282 |
| PFIZER INC. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Bausch Health US, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: VRAYLAR, REXULTI, QULIPTA, NURTEC ODT, APLENZIN, UBRELVY, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across PA — which companies pay providers there.
